Evaluating the impact of cannabis oil for autistic children with and without concomitant medications: Insights from an open-label study
Published online on July 04, 2025
Abstract
Journal of Psychopharmacology, Ahead of Print.
Background:Although only two drugs are FDA approved for autism spectrum disorder (ASD), clinical practice treatment includes off-label use of medications to address the troubling symptoms of ASD. Several trials showed the beneficial effects of medical ...
Background:Although only two drugs are FDA approved for autism spectrum disorder (ASD), clinical practice treatment includes off-label use of medications to address the troubling symptoms of ASD. Several trials showed the beneficial effects of medical ...